Диссертация (1140386), страница 19
Текст из файла (страница 19)
С. 263–8.63.Cronin C.G., Delappe E, Lohan DG,et al. Normal small bowel wallcharacteristics on MR enterography. // Eur. J. Radiol. 2010. Т. 75. № 2. С.207–11.64.Damin D.C., Santos FS, Heck R, et al. Effects of the gastrin-releasing peptideantagonist RC-3095 in a rat model of ulcerative colitis. // Dig. Dis. Sci. 2010.Т. 55. № 8. С. 2203–10.65.Dammen R., Haugen M, Svejda B, et al. The stimulatory adenosine receptorADORA2B regulates serotonin (5-HT) synthesis and release in oxygendepleted EC cells in inflammatory bowel disease. // PLoS One. 2013.
Т. 8. №4. С. e62607.66.Delgado M., Pozo D., Ganea D. The significance of vasoactive intestinalpeptide in immunomodulation. // Pharmacol. Rev. 2004. Т. 56. № 2. С. 249–90.67.Denoya P., Haugen M, Svejda B et al. Granulomas in Crohn’s disease: doesprogression through the bowel layers affect presentation or predict recurrence?// Colorectal Dis. 2011. Т. 13. № 10. С. 1142–7.68.Desmet VJ, Geboes K. Liver lesions in inflammatory bowel disorders. JPathol, 1987; 151: 247-255.12169.Dilauro S., Crum-Cianflone N.F. Ileitis: when it is not Crohn’s disease.
// Curr.Gastroenterol. Rep. 2010. Т. 12. № 4. С. 249–58.70.Durai R., Husain F, Oke T, Siddiqui M., et al. Ileo-ileal intussusception fromCrohn’s ileitis. // Br. J. Hosp. Med. (Lond). 2011. Т. 72. № 11. С. 653.71.Edelblum K., Dynamic migration of γδ intraepithelial lymphocytes requiresoccludin. Proc Natl Acad Sci U S A. 2012 May 1;109(18):7097-102.72.Eduardo Garcia Vilela, Henrique Osvaldo da Gama Torres, Fabiana PaivaMartins, Maria de Lourdes de Abreu Ferrari, et al. Evaluation of inflammatoryactivity in Crohn’s disease and ulcerative colitis.
World J Gastroenterol 2012March 7; 18(9)73.Eduardo Garcia Vilela, Henrique Osvaldo da Gama Torres, Fabiana PaivaMartins, Maria de Lourdes de Abreu Ferrari, et al. Evaluation of inflammatoryactivity in Crohn’s disease and ulcerative colitis. World J Gastroenterol 2012March 7; 18(9)74.Ek W.E., D’Amato M., Halfvarson J. The history of genetics in inflammatorybowel disease.
// Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 2014.Т. 27. № 4. С. 294–303.75.Engel M.A., Becker C, Reeh PW, et al. Role of sensory neurons in colitis:increasing evidence for a neuroimmune link in the gut. // Inflamm. Bowel Dis.2011. Т. 17. № 4. С. 1030–3.76.Epithelioid granulomas, pattern recognition receptors,77.Esworthy R.S., Kim BW, Chow J, et al. Nox1 causes ileocolitis in micedeficient in glutathione peroxidase-1 and -2.
// Free Radic. Biol. Med. 2014. Т.68. С. 315–25.78.Farmer R.G., Whelan G., Fazio V.W. Long-term follow-up of patients withCrohn’s disease. Relationship between the clinical pattern and prognosis. //Gastroenterology. 1985. Т. 88. № 6. С. 1818–25.79.Feakins R.М. Биопсии воспалительной болезни кишечника : обновлениярекомендаций по составлению заключения Британского обществагастроэнтерологов // 1997.
С. 1–40.80.Fernandez A. A “false positive” octreoscan in ileal Crohn’s disease // World J.Gastroenterol. 2008. Т. 14. № 34. С. 5349.81.Fernandez A., Tabuenca O., Peteir A., A “false positive” octreoscan in ilealCrohn’s disease. World J Gastroenterol 2008 September 14; 14 (34): 5349535282.Fitzpatrick L.R. Inhibition of IL-17 as a pharmacological approach for IBD.
//Int. Rev. Immunol. Т. 32. № 5-6. С. 544–55.12283.Franzè E., Caruso R, Stolfi C., et al. Lesional accumulation of CD163expressing cells in the gut of patients with inflammatory bowel disease. //PLoS One. 2013. Т. 8. № 7. С. e69839.84.Freeman H.J. Granuloma-positive Crohn’s disease. // Can. J. Gastroenterol.2007. Т. 21. № 9. С. 583–7.85.Friedrich M., Diegelmann J1, Schauber J., et al. Intestinal neuroendocrine cellsand goblet cells are mediators of IL-17A-amplified epithelial IL-17Cproduction in human inflammatory bowel disease. // Mucosal Immunol. 2014.86.Fries W., Belvedere A., Vetrano S. Sealing the broken barrier in IBD: intestinalpermeability, epithelial cells and junctions. // Curr.
Drug Targets. 2013. Т. 14.№ 12. С. 1460–70.87.Fujino S., Andoh A, Bamba S et al. Increased expression of interleukin 17 ininflammatory bowel disease. // Gut. 2003. Т. 52. № 1. С. 65–70.88.Gálvez J. Role of Th17 Cells in the Pathogenesis of Human IBD. // ISRNInflamm. 2014. Т. 2014. С. 928461.89.Garrido E., Sanromán AL, Rodríguez-Gandía MA, et al. Optimized protocolfor diagnosis of acute ileitis.
// Clin. Gastroenterol. Hepatol. 2009. Т. 7. № 11.С. 1183–8.90.Geboes K, Vantrappen G. The value of colonoscopy in the diagnosis ofCrohn's disease. Gastrointest Endosc, 1975; 22: 18-23.91.Geboes K., van den Oord J, De Wolf-Peeters C., et al. The cellular compositionof granulomas in mesenteric lymph nodes from patients with Crohn’s disease.// Virchows Arch. A.
Pathol. Anat. Histopathol. 1986. Т. 409. № 5. С. 679–92.92.Geiger B.M., Gras-Miralles B, Ziogas DC, et al. Intestinal upregulation ofmelanin-concentrating hormone in TNBS-induced enterocolitis in adultzebrafish. // PLoS One. 2013. Т. 8. № 12. С. e83194.93.Ginj M, Chen J, Walter MA, Eltschinger V, et al., HR 2005 Preclinicalevaluation of new and highly potent analogues of octreotide for predictiveimaging and targeted radiotherapy.
Clin Cancer Res 11:1136–114594.Gougeon P.-Y., Lourenssen S, Han TY, et al. The pro-inflammatory cytokinesIL-1β and TNFα are neurotrophic for enteric neurons. // J. Neurosci. 2013. Т.33. № 8. С. 3339–51.95.Gross K.J., Pothoulakis C. Role of neuropeptides in inflammatory boweldisease. // Inflamm. Bowel Dis.
2007. Т. 13. № 7. С. 918–32.96.Gut 2005;54:215–222.97.Hansen M.B. The enteric nervous system I: organisation and classification. //Pharmacol. Toxicol. 2003a. Т. 92. № 3. С. 105–13.12398.Hansen M.B. The Enteric Nervous System III: A Target for PharmacologicalTreatment // Pharmacol. Toxicol. 2003b. Т. 93. № 1. С.
1–13.99.Heimesaat M.M., Dunay IR, Schulze S.,et al. Pituitary adenylate cyclaseactivating polypeptide ameliorates experimental acute ileitis and extraintestinal sequelae. // PLoS One. 2014. Т. 9. № 9. С. e108389.100.Heresbach D, Heresbach-Le Berre N, Ramée MP, Sémana G, GosselinM, Bretagne JF. Fréquence et valeur pronostique du granulome épithélioïde aucours des maladies inflammatoires chroniques de l’intestin. Gastroenterol ClinBiol, 1999; 23: 1376-1387.101.Heresbach D., Branger, et al. Frequency and significance of granulomasin a cohort of incident cases of Crohn’s disease Gut 2005;54: 215–222.102.Hinojosa J. et al. [Morphological, histochemical and immunochemicalcharacteristics of the terminal ileum of patients with ulcerative colitis.Relationship with the development of pouchitis].
// Gastroenterol. Hepatol.2000. Т. 23. № 6. С. 263–8.103.Hodgson H.J. Pathogenesis of Crohn’s disease. // Baillieres. Clin.Gastroenterol. 1998. Т. 12. № 1. С. 1–17.104.Hofstaedter F. Granulomas may be more than diagnostic tools and couldbe significant in the biology and clinical course of Crohn’s disease Gut2005;54:180–181105.Hovde Ø., Moum B.A. Epidemiology and clinical course of Crohn’sdisease: results from observational studies.
// World J. Gastroenterol. 2012. Т.18. № 15. С. 1723–31.106.Imaeda H. et al. Epithelial expression of interleukin-37b in inflammatorybowel disease. // Clin. Exp. Immunol. 2013. Т. 172. № 3. С. 410–6.107.Janssen C.E.I. et al. Morphologic and immunohistochemicalcharacterization of granulomas in the nucleotide oligomerization domain 2related disorders Blau syndrome and Crohn disease. // J.
Allergy Clin.Immunol. 2012. Т. 129. № 4. С. 1076–84.108.Jiang W. et al. Elevated levels of Th17 cells and Th17-related cytokinesare associated with disease activity in patients with inflammatory boweldisease. // Inflamm. Res. 2014. Т. 63. № 11. С. 943–50.109.Jouret A, Mainguet P. Diagnostic value of systematic endoscopicbiopsies in ileocolonic Crohn's disease. Acta Gastroenterol Belg, 1993; 56:C71.110.Jung S.H. et al. The role of adipose tissue-associated macrophages and Tlymphocytes in the pathogenesis of inflammatory bowel disease. // Cytokine.2013. Т. 61.
№ 2. С. 459–68.124111.Kalafatakis K., Triantafyllou K. Contribution of neurotensin in theimmune and neuroendocrine modulation of normal and abnormal entericfunction. // Regul. Pept. 2011. Т. 170. № 1-3. С. 7–17.112.Kaser A. et al. XBP1 links ER stress to intestinal inflammation andconfers genetic risk for human inflammatory bowel disease. // Cell. 2008.
Т.134. № 5. С. 743–56.113.Kayser K, Probst F, Gabius HJ, Müller KM. Are there characteristicalterations of lung tissue associated with Crohn’s disease. Path Res Pract,1990; 186: 485-490.114.Kelly JK, Sutherland LR. The chronological sequence in the pathologyof Crohn’s disease. J Clin Gastroenterol, 1988; 10: 28-33.115.Kennedy G. et al. Routine ileal intubation during screening colonoscopy:a useful maneuver? // Surg. Endosc.















